Key result
Higher SpO2 in CHD neonates is linked to a shift toward Enterococcus-dominant intestinal microbiota.
Why the study?
Little is known about the composition and dynamics of the intestinal microbiota in infants with congenital heart disease and potential influencing factors.
Does congenital heart disease alter the early life gut microbiota composition in neonates compared to healthy controls?
Observational (n=43)
No
Does congenital heart disease alter the early life gut microbiota composition in neonates compared to healthy controls?
Neonates with congenital heart disease exhibit significant perturbations in early life gut microbiota composition, which appear to be linked to intestinal tissue oxygenation and perfusion.
Answers are grounded in this paper and cite their sources.
Oxygen saturation may shape gut microbiota in CHD neonates; hypothesis-generating and requires prospective studies before any practice implications.
Background Early life gut microbiota is known to shape the immune system and has a crucial role in immune homeostasis. Only little is known about composition and dynamics of the intestinal microbiota in infants with congenital heart disease (CHD) and potential influencing factors. Methods We evaluated the intestinal microbial composition of neonates with CHD ( n = 13) compared to healthy controls (HC, n = 30). Fecal samples were analyzed by shotgun metagenomics. Different approaches of statistical modeling were applied to assess the impact of influencing factors on variation in species composition. Unsupervised hierarchical clustering of the microbial composition of neonates with CHD was used to detect associations of distinct clusters with intestinal tissue oxygenation and perfusion parameters, obtained by the “oxygen to see” (O2C) method. Results Overall, neonates with CHD showed an intestinal core microbiota dominated by the genera Enterococcus (27%) and Staphylococcus (20%). Furthermore, a lower abundance of the genera Bacteroides (8% vs. 14%), Parabacteroides (1% vs. 3%), Bifidobacterium (4% vs. 12%), and Escherichia (8% vs. 23%) was observed in CHD compared to HCs. CHD patients that were born by vaginal delivery showed a lower fraction of the genera Bacteroides (15% vs. 21%) and Bifidobacterium (7% vs. 22%) compared to HCs and in those born by cesarean section, these genera were not found at all. In infants with CHD, we found a significant impact of oxygen saturation (SpO2) on relative abundances of the intestinal core microbiota by multivariate analysis of variance ( F [8,2] = 24.9, p = 0.04). Statistical modeling suggested a large proportional shift from a microbiota dominated by the genus Streptococcus (50%) in conditions with low SpO2 towards the genus Enterococcus (61%) in conditions with high SpO2. We identified three distinct compositional microbial clusters, corresponding neonates differed significantly in intestinal blood flow and global gut perfusion. Conclusion Early life differences in gut microbiota of CHD neonates versus HCs are possibly linked to oxygen levels. Delivery method may affect microbiota stability. However, further studies are needed to assess the effect of potential interventions including probiotics or fecal transplants on early life microbiota perturbations in neonates with CHD.
No takes yet. Share an insight, caveat, or question.
Renk et al. (2025) conducted an observational in Congenital heart disease (n=43). Congenital heart disease (exposure) vs. Healthy controls was evaluated on Impact of oxygen saturation (SpO2) on relative abundances of the intestinal core microbiota in infants with CHD (p=0.04). In neonates with congenital heart disease, oxygen saturation significantly impacted the relative abundances of the intestinal core microbiota (p = 0.04), with a shift towards Enterococcus dominance in higher oxygen conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: